Meeting of senior midwives in the pharmaceutical industry

Paljinhoe, a representative meeting of seniors in the pharmaceutical industry, has concluded their 48-year partnership. Paljinhoe is a friendly gathering established in 1975 by eight owners and managers of major domestic pharmaceutical companies with the intention of ‘let’s move forward together as eight people’. The Paljinhoe, a meeting of elders in the pharmaceutical industry, concluded … Read more

Rana Samaha responds to Zizi Adel’s statements about Star Academy: We were praying inside the academy

The Egyptian actress, Rana Samaha, responded to the statements of her colleague, the retired Egyptian artist, Zizi Adel, about the “Star Academy” program in which they had participated before, even in different seasons, especially since the latter had attacked the program, revealing the presence of cameras in the bathrooms. Samaha said in local statements: “The … Read more

AI predicts age, confirms onset of dementia, 150% higher in old brain

Clinical results have shown that older brains whose age predicted by artificial intelligence (AI) is higher than their actual age are 150% more likely to suffer from dementia. On the 15th, the team led by Professor Chang-Hyung Hong, Sang-Jun Son, and Hyun-Woong Noh of the Department of Psychiatry at Ajou University Hospital conducted a joint … Read more

AI predicts age, confirms onset of dementia, 150% higher in old brain

Clinical results have shown that older brains whose age predicted by artificial intelligence (AI) is higher than their actual age are 150% more likely to suffer from dementia. On the 15th, the team led by Professor Chang-Hyung Hong, Sang-Jun Son, and Hyun-Woong Noh of the Department of Psychiatry at Ajou University Hospital conducted a joint … Read more

Dengue fever quadrivalent vaccine approved in Europe… Licensed by Takeda Qudenga

Takeda Pharmaceutical’s dengue fever vaccine Qdenga expanded its approval to Europe after approval in Indonesia in August. As Takeda continues to apply for vaccine licenses in dengue epidemic countries in Asia and Latin America, European approval is likely to have a positive effect on future approvals from other regulatory agencies. Takeda announced on the 8th … Read more

Researchers around the world are paying attention to the primary effect of Rexraza, a new lung cancer drug

Professor Cho Byung-chul of Severance Hospital is announcing a study on LASER301 on the 3rd, while lung cancer experts around the world are watching. A new domestic lung cancer drug, Lexraza (named Lazertinib), is about to acquire the title as the world’s second 3rd generation EGFR-TKI (Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor) first-line treatment. Professor … Read more